Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma

BACKGROUND: Treatment outcomes of sorafenib therapy may greatly vary depending not only on tumor spread but also on past clinical processes prior to sorafenib therapy and timing of sorafenib administration in the past clinical course of hepatocellular carcinoma (HCC). We evaluated the efficacy of so...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Suzuki, Eiichiro, Inoue, Masanori, Wakamatsu, Toru, Tawada, Akinobu, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990272/
https://www.ncbi.nlm.nih.gov/pubmed/27537374
http://dx.doi.org/10.1371/journal.pone.0161303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990272/
https://www.ncbi.nlm.nih.gov/pubmed/27537374
http://dx.doi.org/10.1371/journal.pone.0161303

Ejemplares similares